52 filings
Page 2 of 3
8-K
rba7v6o
9 Jan 23
Royalty Pharma Highlights Accomplishments and Provides Business Update at 41ST Annual J.P. Morgan Healthcare Conference
9:26am
8-K
mwaykyxezd kitp
1 Dec 22
Material Impairments
4:54pm
8-K
lss7o2 cp4l
8 Nov 22
Results of Operations and Financial Condition
7:32am
8-K
mc8mgh ytkayq
3 Oct 22
Amendments to Articles of Incorporation or Bylaws
5:06pm
8-K
e0dp2dr7
4 Aug 22
Results of Operations and Financial Condition
7:36am
8-K
xul1g6
13 Jul 22
Royalty Pharma Agrees to Acquire Royalty Interest In Trelegy
4:34pm
8-K
nubhdxt f4bai
23 Jun 22
Submission of Matters to a Vote of Security Holders
5:13pm
8-K
twu rcgyg3he602sixgp
17 May 22
Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders
7:37am
8-K
783 6ar8zamlzv
11 May 22
Other Events
11:32am
8-K
g4a8du2l u3fc
5 May 22
Results of Operations and Financial Condition
7:37am
8-K
lp7nt 60maufl37tw
15 Apr 22
Other Events
4:22pm
8-K
6jm68i1n 7xe
4 Apr 22
Changes in Registrant's Certifying Accountant
4:57pm
8-K
qb87zso
15 Feb 22
Results of Operations and Financial Condition
7:55am
8-K
9qin1pjnn05atx5sqx
10 Jan 22
Royalty Pharma Highlights Accomplishments and Provides Business Update at 40TH Annual J.P. Morgan Healthcare Conference
7:37am
8-K
uf8k6
10 Nov 21
Results of Operations and Financial Condition
7:59am
8-K
c75dmdi ks8
11 Aug 21
Results of Operations and Financial Condition
7:47am
8-K
slf2togph5h d1
26 Jul 21
Entry into a Material Definitive Agreement
5:00pm
8-K
72ocqp80
16 Jul 21
Entry into a Material Definitive Agreement
5:11pm
8-K
x489zjf
25 Jun 21
Submission of Matters to a Vote of Security Holders
5:21pm
8-K
3eqvgrbc0
2 Jun 21
Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership with Morphosys
7:51am